[Myeloperoxidase in the Neurodegenerative Process of Parkinson's Disease]
Overview
Authors
Affiliations
Myeloperoxidase (MPO) is a hemoprotein which is involved in the unspecific immune response. In this process hypochloric acid is released. Hypochloric acid can react with lipids and proteins and thus lead to cell damage. We were able to show that MPO, as well as a biomarker for MPO - 3-Chlorotyrosine - are upregulated in the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)-model of Parkinson's disease as well as in the disease itself. Ablation of MPO resulted in a neuroprotective effect in the MPTP-model. Herein we describe the different function of MPO, and how these can lead to the cellular demise as seen in Parkinson's disease.
Neutrophils: a subgroup of neglected immune cells in ALS.
Cao W, Fan D Front Immunol. 2023; 14:1246768.
PMID: 37662922 PMC: 10468589. DOI: 10.3389/fimmu.2023.1246768.
Jang Y, Ahn H, Thi Dao T, Hong J, Shin W, Lim Y Biomater Res. 2023; 27(1):12.
PMID: 36797805 PMC: 9936675. DOI: 10.1186/s40824-023-00353-2.
Reynolds W, Malle E, Maki R Antioxidants (Basel). 2022; 11(12).
PMID: 36552550 PMC: 9774557. DOI: 10.3390/antiox11122342.
Fernandez-Espejo E, Rodriguez de Fonseca F, Gavito A, Cordoba-Fernandez A, Chacon J, Martin de Pablos A Antioxidants (Basel). 2022; 11(6).
PMID: 35739985 PMC: 9219636. DOI: 10.3390/antiox11061088.
The Dual Role of Myeloperoxidase in Immune Response.
Arnhold J Int J Mol Sci. 2020; 21(21).
PMID: 33137905 PMC: 7663354. DOI: 10.3390/ijms21218057.